|
|
Volumn 7, Issue 3, 2002, Pages 119-124
|
|
Quality of life in patients with metastatic renal cell carcinoma participating in a phase I trial of an autologous tumor-derived vaccine
|
|
Author keywords
Kidney neoplasms; Phase I trials; Quality of life
|
|
Indexed keywords
CANCER VACCINE;
HEAT SHOCK PROTEIN COMPLEX 96 VACCINE;
UNCLASSIFIED DRUG;
HEAT SHOCK PROTEIN PEPTIDE COMPLEX 96 VACCINE;
TUMOR VACCINE;
ADULT;
AGED;
ARTICLE;
CANCER IMMUNOTHERAPY;
CANCER MODEL;
CANCER STAGING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EMOTION;
FEMALE;
HEALTH SURVEY;
HUMAN;
KIDNEY CARCINOMA;
MALE;
NEPHRECTOMY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SOCIAL PSYCHOLOGY;
TREATMENT OUTCOME;
FOLLOW UP;
IMMUNOTHERAPY;
METASTASIS;
PHASE 1 CLINICAL TRIAL;
PROSPECTIVE STUDY;
SCORING SYSTEM;
ATTITUDE TO HEALTH;
CANCER VACCINES;
CARCINOMA, RENAL CELL;
DIABETES MELLITUS, TYPE 2;
EDUCATIONAL STATUS;
EMOTIONS;
EMPLOYMENT;
HEALTH STATUS;
HEART FAILURE, CONGESTIVE;
HUMANS;
MENTAL HEALTH;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
QUALITY OF LIFE;
QUESTIONNAIRES;
URINARY BLADDER NEOPLASMS;
|
|
EID: 0036236563
PISSN: 10781439
EISSN: None
Source Type: Journal
DOI: 10.1016/S1078-1439(01)00182-X Document Type: Article |
|
Times cited : (36)
|
|
References (26)
|
